Abstract
The antihypertensive efficacies of lisinopril and captopril were compared using office sphygmomanometry and 24-h ambulatory blood pressure monitoring. In a double-blind, prospective, randomly allocated trial, the patients were given increasing doses of captopril at 25-100 mg twice a day or lisinopril at 10-40 mg once a day until a clinical response was achieved or the highest dose was reached. A response was defined as a reduction in diastolic pressure below 90 mmHg or a fall of at least 10 mmHg from baseline. The ambulatory monitoring showed that lisinopril reduced blood pressure from baseline to the final value and maintained the reduction to a greater degree than captopril throughout 24-h periods of observation. The office measurements showed a similar trend, but the intertreatment differences did not reach statistical significance. No first-dose side effects were observed with either drug. Once a day lisinopril appeared to be a more effective antihypertensive regimen than twice a day captopril.
Original language | English (US) |
---|---|
Journal | Journal of Hypertension |
Volume | 9 |
Issue number | SUPPL. 1 |
State | Published - 1991 |
Fingerprint
ASJC Scopus subject areas
- Endocrinology
- Internal Medicine
Cite this
Application of ambulatory blood pressure monitoring to clinical therapeutic decisions in hypertension. / Whelton, A.
In: Journal of Hypertension, Vol. 9, No. SUPPL. 1, 1991.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Application of ambulatory blood pressure monitoring to clinical therapeutic decisions in hypertension
AU - Whelton, A.
PY - 1991
Y1 - 1991
N2 - The antihypertensive efficacies of lisinopril and captopril were compared using office sphygmomanometry and 24-h ambulatory blood pressure monitoring. In a double-blind, prospective, randomly allocated trial, the patients were given increasing doses of captopril at 25-100 mg twice a day or lisinopril at 10-40 mg once a day until a clinical response was achieved or the highest dose was reached. A response was defined as a reduction in diastolic pressure below 90 mmHg or a fall of at least 10 mmHg from baseline. The ambulatory monitoring showed that lisinopril reduced blood pressure from baseline to the final value and maintained the reduction to a greater degree than captopril throughout 24-h periods of observation. The office measurements showed a similar trend, but the intertreatment differences did not reach statistical significance. No first-dose side effects were observed with either drug. Once a day lisinopril appeared to be a more effective antihypertensive regimen than twice a day captopril.
AB - The antihypertensive efficacies of lisinopril and captopril were compared using office sphygmomanometry and 24-h ambulatory blood pressure monitoring. In a double-blind, prospective, randomly allocated trial, the patients were given increasing doses of captopril at 25-100 mg twice a day or lisinopril at 10-40 mg once a day until a clinical response was achieved or the highest dose was reached. A response was defined as a reduction in diastolic pressure below 90 mmHg or a fall of at least 10 mmHg from baseline. The ambulatory monitoring showed that lisinopril reduced blood pressure from baseline to the final value and maintained the reduction to a greater degree than captopril throughout 24-h periods of observation. The office measurements showed a similar trend, but the intertreatment differences did not reach statistical significance. No first-dose side effects were observed with either drug. Once a day lisinopril appeared to be a more effective antihypertensive regimen than twice a day captopril.
UR - http://www.scopus.com/inward/record.url?scp=0026035384&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026035384&partnerID=8YFLogxK
M3 - Article
C2 - 1645768
AN - SCOPUS:0026035384
VL - 9
JO - Journal of Hypertension
JF - Journal of Hypertension
SN - 0263-6352
IS - SUPPL. 1
ER -